SAS vs. SAS vs. Phoenix [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-11-12 14:01 (1991 d 16:04 ago) – Posting: # 20788
Views: 11,205

Hi to all victims of the partial replicate with incomplete data,

following extensive off-list discussions with PharmCat (who is working on a Julia-library; see here and there) I checked again what we got with the FDA’s covariance structure, Satterthwaite’s df (PE, 90% CI).
Not the slightest idea how I arrived at the results given above. Sorry for the confusion caused.
In all cases simplifying the covariance structure (in SAS-lingo FA0(1) instead of the FA0(2) in the guidance): Convergence without warning.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
31 visitors (0 registered, 31 guests [including 8 identified bots]).
Forum time: 07:06 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5